AnaptysBio Inc diskutieren
AnaptysBio Inc
WKN: A2AJ8C / Symbol: ANAB / Name: AnaptysBio / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
44,87 €
1,45 %
AnaptysBio (NASDAQ:ANAB) was given a new $70.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its price target lowered by analysts at HC Wainwright from $52.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its price target lowered by analysts at Stifel Nicolaus from $80.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by HC Wainwright from $51.00 to $66.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by Barclays PLC from $78.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by Stifel Nicolaus from $56.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by Wedbush from $60.00 to $75.00. They now have an "outperform" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by UBS Group AG from $70.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $66.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target raised by Piper Sandler from $67.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its price target lowered by Barclays PLC from $79.00 to $63.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) was given a new $85.00 price target by Leerink Partners. They now have an "outperform" rating on the stock.
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for ANAB provided by MarketBeat
Neueste Beiträge
Susquehanna in Canadian Pacific Railway diskutieren, Canadian Pacific City Kansas Ltd.